5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.
D000437:Alcoholism / Q000188:drug therapy; D001714:Bipolar Disorder / Q000134:cerebrospinal fluid; D002493:Central Nervous System Diseases / Q000134:cerebrospinal fluid*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007099:Imipramine / Q000627:therapeutic use; D001523:Mental Disorders / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000134:cerebrospinal fluid
D006897:Hydroxyindoleacetic Acid; D007099:Imipramine